All News

Urology drugs and devices that are in the pipeline from Rexahn Pharmaceuticals, Inc., CytRx Corp., Urigen Pharmaceuticals, Inc., Seattle Genetics, Inc., Agensys, Inc., and Millennium: The Takeda Oncology Co.

In diagnosing and treating infection and inflammation, urologists increasingly are using approaches tailored to specific pathogens, patients, and clinical situations.

This year's AUA annual meeting will bring an important first for interstitial cystitis: AUA will be issuing guidelines for diagnosis and treatment.

The advent of robot-assisted surgery is allowing more urologists to perform complex procedures-partial nephrectomies, in particular-which in turn contributes to better patient outcomes.

The number of urodynamic studies conducted by urologists applying for board certification or recertification more than doubled in less than a decade, with most of the procedures being performed in men with symptoms of urinary obstruction and in women with urinary incontinence.

Teva Pharmaceutical Industries Ltd. and Mylan Inc. have separately announced that they received FDA approval for generic versions of tamsulosin hydrochloride capsules, 0.4 mg, for the treatment of signs and symptoms of BPH.

Pinnacle Business Solutions Inc. Medicare Services has announced the retirement of least costly alternative (LCA) local coverage determinations (LCDs) for certain prostate cancer drugs, a move AUA called a "welcome development."

The risk of prostate cancer increases with the number of directly related family members who are affected by the disease, researchers at the German Cancer Research Center in Heidelberg reported.

A blood test for certain forms of PSA and measurement of DNA content in biopsy tissue accurately predict which men with potentially non-lethal prostate cancers may eventually need treatment, say urologists from Johns Hopkins University, Baltimore.

Gonadotropin-releasing hormone (GnRH) agonists have been associated with a small increased risk for diabetes, heart attack, stroke, and sudden death in men treated with one of the medications, according to a preliminary and ongoing analysis of several FDA studies.

Urology drugs and devices that are in the pipeline.

Urologists should be aware of the links between hypogonadism and other serious health issues, as androgen deficiency may be the first clinically apparent sign of additional, future medical problems.

This list of U.S.-based National Institutes of Health trials is derived from the NIH's database and includes U.S. phase II bladder cancer trials that are currently recruiting participants. This list is current as of April 7, 2010.

The two biggest issues that come to mind in light of the current economic climate are how well you're communicating within the urology practice and how the economy might affect staff performance.

San Francisco has cuisine to satisfy any taste buds. From dim sum to gnocchi, use this guide to map out your dining tour of the city by the bay. Note: All phone numbers use the area code 415.

The more knowledge we have, the better informed decisions we'll be able to promote and help our patients make.

Plenty of experience fixing complications of pelvic reconstruction and incontinence surgery caused by foreign bodies-mainly grafts and slings-led a group of researchers to make recommendations on how to repair the damage.

A trial currently under way may help urologists to separate responders from nonresponders early and tailor BCG therapy for optimal results in those bladder cancer patients who respond to the drug.

It may be time to put surgical-style checklists to use in the office. This article, which details one of the author's own experience, explains why.

San Francisco's diverse and unique offerings-neighborhoods, attractions, arts, culture, and nightlife-are unparalleled in the United States.

As part of reform, It is clear that the government is starting to tighten control of physician-owned ancillary services.

Urologists and their patients may soon be able to determine renal cell tumor histology without surgery or biopsy.

Injections of autologous muscle-derived cells appear to be both safe and effective in the treatment of stress urinary incontinence, with a trend toward greater effectiveness at higher doses.

Overall, most of the urologists who were interviewed considered the CT scan the gold standard for approaching many diagnoses.

What is it going to take for Congress to stop playing games with physicians who treat Medicare patients and develop an effective solution to the fee cuts that are scheduled every year and require last-minute, short-term solutions?

Significant time is spent developing methods or strategies that come close to that "perfect investment." None is as popular or compelling as Modern Portfolio Theory.

Although the request to revise the urodynamics codes was initiated by Medicare, the request was to change the CPT code descriptions to reflect the fact that the old 51772 and the old 51795 were billed in conjunction with code 51726 almost all the time.